Moreover, HER2-CAR-Ms demonstrated the ability to polarise M2 macrophages into M1 macrophages, incite the formation of an inflammatory TME, and increase T cell cytotoxicity against tumours. This evidence concerns the gene ERBB2 and neoplasm.